TITLE

FORMATION AND SIZE OF PLATELET AGGREGATES DURING HYPOVOLEMIC HYPOTENSION IN DOG

AUTHOR(S)
Lauterjung, K. L.; Isselhard, W.
PUB. DATE
February 1973
SOURCE
Angiology;Feb1973, Vol. 24 Issue 2, p107
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Platelet aggregation in the dog during hypovolemic hypotension is followed up by a fotoelectrical method. This method allows for a continuous determination of aggregate concentration and aggregate size simultaneously in arterial and venous blood. The different time course of platelet aggregation in arterial and venous blood shows the venous origin of aggregation, and reveals the filtering properties of the canine lung.
ACCESSION #
16358530

 

Related Articles

  • METABOLISM OF SKELETAL MUSCLE FOLLOWING INCOMPLETE ISCHEMIA. Arcangeli, P.; Digiesi, V.; Masala, B.; Serra, M. V.; Congiu, A. // Angiology;Feb1973, Vol. 24 Issue 2, p114 

    The metabolic responses in sural muscles ischemized by ligatures of the femoral artery and stenosis of the common iliac artery are reported. The glyco- lyric and oxidative enzyme systems are at first stimulated and then depressed but finally returning to normal. The incorporation of C14-1eucine...

  • HYPERURICEMIA IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE. Seitanidis, Basil; Balas, P.; Karabelis, A.; Tripolitis, A. // Angiology;Apr1974, Vol. 25 Issue 4, p257 

    Serum uric acid was found elevated in 25 out of 45 patients with Peripheral arterial occlusive disease. At the present time neither the precise pathogenesis of PAOD nor the exact role of SUA in vascular disorders has been determined. There exists some data suggesting on the one hand a...

  • Platelet Aggregation and Thrombotic Vascular Disease. Colman, Robert W. // Annals of Internal Medicine;Jun75, Vol. 82 Issue 6, p839 

    Editorial. Discusses research on platelet aggregation and thrombotic vascular disease. Types of thrombotic vascular disease associated with platelet aggregation.

  • Differing effect of modifiable cardiovascular risk factors on intima-media thickening and plaque formation at different sites of the arterial vasculature. Chaubey, Sanjay; Nitsch, Dorothea; Altmann, Daniel; Ebrahim, Shah // Heart;Oct2010, Vol. 96 Issue 19, p1579 

    Objective The effects of cardiovascular risk factors on the vascular anatomy at differing sites of the arterial vasculature have not been well described. The aim of this study was to compare the effect of cardiovascular risk factors on the intima media thickness (IMT) of the wall of the right...

  • Treatment of Chronic Peripheral Arterial Disease. Antignani, P.L. // Current Vascular Pharmacology;Jun2003, Vol. 1 Issue 2, p205 

    Peripheral arterial disease (PAD) is a common but under-recognized problem. Intermittent claudication is the most frequent symptom of PAD, although the diagnosis of PAD is often overlooked until the patient is presented with limb-threatening ischemia. Importantly, PAD is a marker of generalized...

  • Diagnostic Value of Captopril Test in Hypertensive Patients with Renal Artery Stenosis. Takata, Masanobu; Yoshida, Koshiro; Tomoda, Fumihiro; Oh-Hashi, Shinya; Ueno, Hitoshi; Yasumoto, Kotaro; Iida, Hiroyuki; Sasayama, Shigetake // Angiology;Mar1994, Vol. 45 Issue 3, p181 

    To examine the utility of the single-dose captopril test in detecting renovascular hypertension (RVHT), the authors measured peripheral plasma renin activity (PRA), before and thirty and sixty minutes after an oral dose of captopril (25 mg), in 28 patients with RVHT and 22 patients with...

  • A DOUBLE--BLIND STUDY OF CHLORTHALIDONE AND HYDROCHLOROTHIAZIDE IN AN OUTPATIENT POPULATION OF MODERATE HYPERTENSIVES. Finnerty Jr., Frank A. // Angiology;Dec1976, Vol. 27 Issue 12, p738 

    Demonstrates the importance of achieving and maintaining control of moderate hypertension; Administration of the hypertensive therapy; Characterization of patients with hypertension; Determination of the comparative efficacy and safety of chlorthalidone and hydrochlorothiazide in the treatment...

  • Eptifibatide: A Review of its Use in Patients with Acute Coronary Syndromes and/or Undergoing Percutaneous Coronary Intervention. Curran, Monique P.; Keating, Gillian M. // Drugs;2005, Vol. 65 Issue 14, p2009 

    Eptifibatide (Integrilin®) is a highly specific, reversible, intravenously administered glycoprotein (GP) IIb/IIIa receptor antagonist that acts at the final common step of the platelet aggregation pathway. Data from large clinical trials indicate that intravenous eptifibatide as adjunctive...

  • MEASURES TO INCREASE THE CAPACITY OF THE COLLATERAL ARTERIAL CIRCULATION IN THE TREATMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE. Popkin, Roy J. // Angiology;Dec1959, Vol. 10 Issue 6, p431 

    1. The collateral arterial circulation in the body is extensive and capable of providing adequate passageways for the arterial flow especially when the major vessels are occluded. 2. A reduction of the normal arterial inflow as from an occlusion and muscle activity distally are both necessary...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics